Stem Cells Treatment in Amyotrophic Lateral Sclerosis

Posted at July 4, 2009
Amina, 43 yrs, was diagnosed with ALS (Amyotrophic lateral sclerosis) only one year ago. Her condition since then has deteriorated to the point where she could no longer use her arms and legs, and had to use the help of caregivers for all her personal daily care, helping her in washing, dressing, getting in and out of bed.
While being dressed, or forced to make big movements, she suffered great pain in her muscles. She needed someone to feed her as she did not have enough strength to bring her hands to her mouth, she could not hold a cup of water, or even turn the pages of a book.
After getting stem cell treatment, her muscles got stronger, and were now more open and flexible; she could hold herself in a sitting position on the bed without support.
Amina says, “I can participate more in the process of dressing, washing up and transporting myself from one place to another and the muscle pain that i suffered during these activities was greatly reduced.” Amina’s voice showed a little improvement in getting louder and stronger, and her speech, though still slow, could be better understood.
Amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig’s disease, is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles. The disease belongs to a group of disorders known as motor neuron diseases, which are characterized by the gradual degeneration and death of motor neurons.
“Stem cell treatment is at a nascent stage but we need to understand the life-saving potential of such procedures. ALS causes weakness with a wide range of disabilities. Most people with ALS die from respiratory failure, usually within 3 to 5 years from the onset of symptoms. However, about 10 percent of ALS patients survive for 10 or more years”, said Karan Goel, an entrepreneur and chairman of Stem Cell Global Foundation, which is creating awareness about stem cell technology.
“ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people also can develop the disease. Men are affected more often than women”, Karan said.
Stem Cells are showing more & more potential in the treatment of various diseases and the challenge we now face is proving their effectiveness for large numbers of people.
Source:
Stem Cell Global Foundation
India: +91-9779277776
USA :+1-877-824-2450
Europe: +44-203-004-9359
Email: info@scvi.in
Website: www.scvi.in

Amina, 43 yrs, was diagnosed with ALS (Amyotrophic lateral sclerosis) only one year ago. Her condition since then has deteriorated to the point where she could no longer use her arms and legs, and had to use the help of caregivers for all her personal daily care, helping her in washing, dressing, getting in and out of bed.

While being dressed, or forced to make big movements, she suffered great pain in her muscles. She needed someone to feed her as she did not have enough strength to bring her hands to her mouth, she could not hold a cup of water, or even turn the pages of a book.

After getting stem cell treatment, her muscles got stronger, and were now more open and flexible; she could hold herself in a sitting position on the bed without support.

Amina says, “I can participate more in the process of dressing, washing up and transporting myself from one place to another and the muscle pain that i suffered during these activities was greatly reduced.” Amina’s voice showed a little improvement in getting louder and stronger, and her speech, though still slow, could be better understood.

Amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig’s disease, is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles. The disease belongs to a group of disorders known as motor neuron diseases, which are characterized by the gradual degeneration and death of motor neurons.

“Stem cell treatment is at a nascent stage but we need to understand the life-saving potential of such procedures. ALS causes weakness with a wide range of disabilities. Most people with ALS die from respiratory failure, usually within 3 to 5 years from the onset of symptoms. However, about 10 percent of ALS patients survive for 10 or more years”, said Karan Goel, an entrepreneur and chairman of Stem Cell Global Foundation, which is creating awareness about stem cell technology.

“ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people also can develop the disease. Men are affected more often than women”, Karan said.

Stem Cells are showing more & more potential in the treatment of various diseases and the challenge we now face is proving their effectiveness for large numbers of people.

Source:

Stem Cell Global Foundation
India: +91-9779277776
USA :+1-877-824-2450
Europe: +44-203-004-9359
Email: info@scvi.in
Website: www.scvi.in

Details on Lou Gehrig’s disease:  http://www.stemcellgf.org/Amyotrophic_Lateral_Sclerosis_(Lou_Gehrig_disease).aspx

Details on other diseases – Please visit http://stemcellgf.org/Diseases.aspx

Interested in cord blood banking – Please visit http://stemcellgf.org/provider-cord-blood-banking.aspx

Press Release

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Leave Comment

(required)

(required)